Literature DB >> 20229155

[Diabetes and cardiovascular complications].

Michael Resl1, Martin Clodi.   

Abstract

The prevalence of obesity and diabetes is increasing dramatically. Currently, 800,000 patients are suffering from diabetes mellitus in Austria. Chronic hyperglycemia results in micro- and macrovascular complications, which reduce life expectancy up to 8 years. Furthermore, diabetes is among the most important risk factors for premature atherosclerosis and coronary artery disease. The incidence of coronary artery disease in diabetics is relatively high with about 146 cases per 10,000 patient years. Apart, it could be demonstrated that the presence of diabetes mellitus worsens the prognosis after an acute coronary syndrome. Considering ischemic stroke, the situation is nearly the same, as it is known that diabetes mellitus increases the risk for ischemic stroke events up to 5 times. Beside the macrovascular complications, microvascular complications like diabetic retinopathy, diabetic nephropathy and diabetic neuropathy also play a critical role. Retinopathy can be detected in nearly every patient after a diabetes duration of 20 years. Diabetic nephropathy, which is a major complication of diabetes mellitus, accounts for 19% of end stage renal disease. Microalbuminuria, which is an early marker of diabetic nephropathy, can be found in 30% of the patients after 10 years of diabetes. Due to the severity of the diabetic complications an early intensified antidiabetic treatment is highly important for the prevention of micro- and macrovascular events.

Entities:  

Mesh:

Year:  2010        PMID: 20229155     DOI: 10.1007/s10354-010-0744-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  43 in total

Review 1.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Raelene E Maser; Braxton D Mitchell; Roy Freeman
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

Review 3.  Preventing foot ulcers in patients with diabetes.

Authors:  Nalini Singh; David G Armstrong; Benjamin A Lipsky
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

4.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

5.  Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome.

Authors:  Richard M Cubbon; Adil Rajwani; Afroze Abbas; Christopher P Gale; Peter J Grant; Stephen B Wheatcroft; Julian H Barth; Mark T Kearney; Alistair S Hall
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-10

6.  The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

Authors:  P Fioretto; M L Caramori; M Mauer
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

7.  Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population.

Authors:  J Tuomilehto; D Rastenyte; P Jousilahti; C Sarti; E Vartiainen
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

10.  Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control.

Authors:  Gail K Adler; Istvan Bonyhay; Hannah Failing; Elizabeth Waring; Sarah Dotson; Roy Freeman
Journal:  Diabetes       Date:  2008-12-03       Impact factor: 9.461

View more
  6 in total

1.  Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma.

Authors:  Thomas W Link; Graeme F Woodworth; Kaisorn L Chaichana; Stuart A Grossman; Robert S Mayer; Henry Brem; Jon D Weingart; Alfredo Quinones-Hinojosa
Journal:  J Clin Neurosci       Date:  2012-05-15       Impact factor: 1.961

2.  Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

Authors:  Florian Hucke; Wolfgang Sieghart; Maximilian Schöniger-Hekele; Markus Peck-Radosavljevic; Christian Müller
Journal:  Wien Klin Wochenschr       Date:  2011-07-29       Impact factor: 1.704

3.  Cross-sectional pilot study about the health status of diabetic patients in city of Misurata, Libya.

Authors:  A S Elhwuegi; A A Darez; A M Langa; N A Bashaga
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 4.  [Diabetes mellitus and cognitive decline].

Authors:  Bernhard Iglseder
Journal:  Wien Med Wochenschr       Date:  2011-07-29

5.  Autophagy and its link to type II diabetes mellitus.

Authors:  Jai-Sing Yang; Chi-Cheng Lu; Sheng-Chu Kuo; Yuan-Man Hsu; Shih-Chang Tsai; Shih-Yin Chen; Yng-Tay Chen; Ying-Ju Lin; Yu-Chuen Huang; Chao-Jung Chen; Wei-De Lin; Wen-Lin Liao; Wei-Yong Lin; Yu-Huei Liu; Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

6.  Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg-Ay/J mice and a Taiwanese Han Chinese population.

Authors:  Chi-Cheng Lu; Yng-Tay Chen; Shih-Yin Chen; Yuan-Man Hsu; Chyi-Chyang Lin; Je-Wei Tsao; Yu-Ning Juan; Jai-Sing Yang; Fuu-Jen Tsai
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.